Potential prognostic marker ubiquitin carboxyl-terminal hydrolase-L1 does not predict patient survival in non-small cell lung carcinoma

Journal of Experimental and Clinical Cancer Research

Volumn 30, Issue 1, 2011, Pages

  Orr, Katy S ^a   Shi, Zhanzhong ^a   Brown, W Mark ^a   O'Hagan, Kathleen A ^a   Lappin, Terence R ^a   Maxwell, Perry ^a   Percy, Melanie J ^a  

^a QUEEN'S UNIVERSITY BELFAST   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

EOSIN; HEMATOXYLIN; MYOSIN LIGHT CHAIN 2; NICOTINAMIDE ADENINE DINUCLEOTIDE ADENOSINE DIPHOSPHATE RIBOSYLTRANSFERASE 1; SMALL INTERFERING RNA; UBIQUITIN THIOLESTERASE; UBIQUITIN THIOLESTERASE L1; UNCLASSIFIED DRUG; MESSENGER RNA; UCHL1 PROTEIN, HUMAN;

ADENOCARCINOMA; ARTICLE; CANCER PATIENT; CANCER STAGING; CANCER SURVIVAL; CELL DEATH; CONTROLLED STUDY; FLOW CYTOMETRY; GENE EXPRESSION; GENE SILENCING; HUMAN; HUMAN CELL; IMMUNOHISTOCHEMISTRY; LUNG NON SMALL CELL CANCER; METASTASIS; NUCLEOTIDE SEQUENCE; PHENOTYPE; PREDICTION; PRIORITY JOURNAL; PROGNOSIS; PROTEIN CLEAVAGE; PROTEIN PHOSPHORYLATION; SQUAMOUS CELL CARCINOMA; TISSUE MICROARRAY; CELL ADHESION; CELL MOTION; CELL PROLIFERATION; DRUG ANTAGONISM; ENZYME IMMUNOASSAY; ENZYMOLOGY; GENETICS; LUNG TUMOR; METABOLISM; MORTALITY; REAL TIME POLYMERASE CHAIN REACTION; SURVIVAL RATE; TUMOR CELL CULTURE; WESTERN BLOTTING;

ADENOCARCINOMA; BLOTTING, WESTERN; CARCINOMA, NON-SMALL-CELL LUNG; CARCINOMA, SQUAMOUS CELL; CELL ADHESION; CELL MOVEMENT; CELL PROLIFERATION; HUMANS; IMMUNOENZYME TECHNIQUES; LUNG NEOPLASMS; NEOPLASM STAGING; PROGNOSIS; REAL-TIME POLYMERASE CHAIN REACTION; RNA, MESSENGER; RNA, SMALL INTERFERING; SURVIVAL RATE; TISSUE ARRAY ANALYSIS; TUMOR CELLS, CULTURED; UBIQUITIN THIOLESTERASE;

EID: 80052116889     PISSN: None     EISSN: 17569966     Source Type: Journal    
DOI: 10.1186/1756-9966-30-79     Document Type: Article

References (41)

1. The ubiquitin-proteasome pathway and its role in cancer. Mani A, Gelmann EP, J Clin Oncol 2005 23 4776 4789 10.1200/JCO.2005.05.081 16034054 (Pubitemid 46224082)
2. Proteasome-independent functions of ubiquitin in endocytosis and signaling. Mukhopadhyay D, Riezman H, Science 2007 315 201 205 10.1126/science.1127085 17218518 (Pubitemid 46166358)
3. The de-ubiquitinase UCH-L1 is an oncogene that drives the development of lymphoma in vivo by deregulating PHLPP1 and Akt signaling. Hussain S, Foreman O, Perkins SL, Witzig TE, Miles RR, van Deursen J, Galardy PJ, Leukemia 2010 24 1641 1655 10.1038/leu.2010.138 20574456
4. DUBs and cancer: the role of deubiquitinating enzymes as oncogenes, non-oncogenes and tumor suppressors. Hussain S, Zhang Y, Galardy PJ, Cell Cycle 2009 8 1688 1697 10.4161/cc.8.11.8739 19448430
5. The functions of UCH-L1 and its relation to neurodegenerative diseases. Setsuie R, Wada K, Neurochem Int 2007 51 105 111 10.1016/j.neuint.2007.05.007 17586089 (Pubitemid 47179898)
6. Regulation of ubiquitin-dependent processes by deubiquitinating enzymes. Wilkinson KD, FASEB J 1997 11 1245 1256 9409543 (Pubitemid 27527888)
7. The potential role of ubiquitin c-terminal hydrolases in oncogenesis. Fang Y, Fu D, Shen XZ, Biochim Biophys Acta 2010 1806 1 6 20302916
8. The UCH-L1 gene encodes two opposing enzymatic activities that affect alpha-synuclein degradation and Parkinson's disease susceptibility. Liu Y, Fallon L, Lashuel HA, Liu Z, Lansbury PT Jr, Cell 2002 111 209 218 10.1016/S0092-8674(02)01012-7 12408865 (Pubitemid 35292441)
9. Epigenetic identification of ubiquitin carboxyl-terminal hydrolase L1 as a functional tumor suppressor and biomarker for hepatocellular carcinoma and other digestive tumors. Yu J, Tao Q, Cheung KF, Jin H, Poon FF, Wang X, Li H, Cheng YY, Rocken C, Ebert MP, Chan AT, Sung JJ, Hepatology 2008 48 508 518 10.1002/hep.22343 18666234
10. The neuron-specific protein PGP 9.5 is a ubiquitin carboxyl-terminal hydrolase. Wilkinson KD, Lee KM, Deshpande S, Duerksen-Hughes P, Boss JM, Pohl J, Science 1989 246 670 673 10.1126/science.2530630 2530630 (Pubitemid 19283361)
11. The new function of two ubiquitin C-terminal hydrolase isozymes as reciprocal modulators of germ cell apoptosis. Kwon J, Exp Anim 2007 56 71 77 10.1538/expanim.56.71 17460351 (Pubitemid 46711790)
12. Role of ubiquitin carboxy terminal hydrolase-L1 in neural cell apoptosis induced by ischemic retinal injury in vivo. Harada T, Harada C, Wang YL, Osaka H, Amanai K, Tanaka K, Takizawa S, Setsuie R, Sakurai M, Sato Y, Noda M, Wada K, Am J Pathol 2004 164 59 64 10.1016/S0002-9440(10)63096-9 14695319 (Pubitemid 38364590)
13. Regulation of apoptosis proteins in cancer cells by ubiquitin. Zhang HG, Wang J, Yang X, Hsu HC, Mountz JD, Oncogene 2004 23 2009 2015 10.1038/sj.onc.1207373 15021888 (Pubitemid 38496730)
14. Dopaminergic neuronal loss in transgenic mice expressing the Parkinson's disease-associated UCH-L1 I93M mutant. Setsuie R, Wang YL, Mochizuki H, Osaka H, Hayakawa H, Ichihara N, Li H, Furuta A, Sano Y, Sun YJ, Kwon J, Kabuta T, Yoshimi K, Aoki S, Mizuno Y, Noda M, Wada K, Neurochem Int 2007 50 119 129 10.1016/j.neuint.2006.07.015 16965839 (Pubitemid 44879668)
15. Analysis of the UCHL1 genetic variant in Parkinson's disease among Chinese. Tan EK, Lu CS, Peng R, Teo YY, Wu-Chou YH, Chen RS, Weng YH, Chen CM, Fung HC, Tan LC, Zhang ZJ, An XK, Lee-Chen GJ, Lee MC, Fook-Chong S, Burgunder JM, Wu RM, Wu YR, Neurobiol Aging 2009 31 2194 2196 19329225
16. Silencing of the UCHL1 gene in human colorectal and ovarian cancers. Okochi-Takada E, Nakazawa K, Wakabayashi M, Mori A, Ichimura S, Yasugi T, Ushijima T, Int J Cancer 2006 119 1338 1344 10.1002/ijc.22025 16642472 (Pubitemid 44258809)
17. Ubiquitin COOH-terminal hydrolase 1: a biomarker of renal cell carcinoma associated with enhanced tumor cell proliferation and migration. Seliger B, Fedorushchenko A, Brenner W, Ackermann A, Atkins D, Hanash S, Lichtenfels R, Clin Cancer Res 2007 13 27 37 10.1158/1078-0432.CCR-06-0824 17200335 (Pubitemid 46121849)
18. CpG hypermethylation of the UCHL1 gene promoter is associated with pathogenesis and poor prognosis in renal cell carcinoma. Kagara I, Enokida H, Kawakami K, Matsuda R, Toki K, Nishimura H, Chiyomaru T, Tatarano S, Itesako T, Kawamoto K, Nishiyama K, Seki N, Nakagawa M, J Urol 2008 180 343 351 10.1016/j.juro.2008.02.044 18499164
19. The role of PGP9.5 as a tumor suppressor gene in human cancer. Tokumaru Y, Yamashita K, Kim MS, Park HL, Osada M, Mori M, Sidransky D, Int J Cancer 2008 123 753 759 10.1002/ijc.23354 18512240 (Pubitemid 352032399)
20. PGP9.5 promoter methylation is an independent prognostic factor for esophageal squamous cell carcinoma. Mandelker DL, Yamashita K, Tokumaru Y, Mimori K, Howard DL, Tanaka Y, Carvalho AL, Jiang WW, Park HL, Kim MS, Osada M, Mori M, Sidransky D, Cancer Res 2005 65 4963 4968 10.1158/0008-5472.CAN-04-3923 15930319 (Pubitemid 40740837)
21. Methylation status in the promoter region of the human PGP9.5 gene in cancer and normal tissues. Bittencourt Rosas SL, Caballero OL, Dong SM, da Costa Carvalho Mda G, Sidransky D, Jen J, Cancer Lett 2001 170 73 79 10.1016/S0304-3835(01)00449-9 11448537 (Pubitemid 32607663)
22. PGP9.5 methylation in diffuse-type gastric cancer. Yamashita K, Park HL, Kim MS, Osada M, Tokumaru Y, Inoue H, Mori M, Sidransky D, Cancer Res 2006 66 3921 3927 10.1158/0008-5472.CAN-05-1511 16585221
23. Useful markers for detecting minimal residual disease in cases of neuroblastoma. Ootsuka S, Asami S, Sasaki T, Yoshida Y, Nemoto N, Shichino H, Chin M, Mugishima H, Suzuki T, Biol Pharm Bull 2008 31 1071 1074 10.1248/bpb.31.1071 18520032 (Pubitemid 351871153)
24. PGP9.5 as a candidate tumor marker for non-small-cell lung cancer. Hibi K, Westra WH, Borges M, Goodman S, Sidransky D, Jen J, Am J Pathol 1999 155 711 715 10.1016/S0002-9440(10)65169-3 10487828 (Pubitemid 29426816)
25. Expression of protein gene product 9.5 (PGP9.5)/ubiquitin-C-terminal hydrolase 1 (UCHL-1) in human myeloma cells. Otsuki T, Yata K, Takata-Tomokuni A, Hyodoh F, Miura Y, Sakaguchi H, Hatayama T, Hatada S, Tsujioka T, Sato Y, Murakami H, Sadahira Y, Sugihara T, Br J Haematol 2004 127 292 298 10.1111/j.1365-2141.2004.05205.x 15491288 (Pubitemid 39468942)
26. Human prostate cancer cells express neuroendocrine cell markers PGP 9.5 and chromogranin A. Leiblich A, Cross SS, Catto JW, Pesce G, Hamdy FC, Rehman I, Prostate 2007 67 1761 1769 10.1002/pros.20654 17929277 (Pubitemid 350228728)
27. Comparative proteomic analysis of osteosarcoma cell and human primary cultured osteoblastic cell. Liu X, Zeng B, Ma J, Wan C, Cancer Invest 2009 27 345 352 10.1080/07357900802438577 19212829
28. PGP9.5 as a prognostic factor in pancreatic cancer. Tezel E, Hibi K, Nagasaka T, Nakao A, Clin Cancer Res 2000 6 4764 4767 11156232 (Pubitemid 32110417)
29. PGP9.5 as a marker for invasive colorectal cancer. Yamazaki T, Hibi K, Takase T, Tezel E, Nakayama H, Kasai Y, Ito K, Akiyama S, Nagasaka T, Nakao A, Clin Cancer Res 2002 8 192 195 11801558 (Pubitemid 34101477)
30. High expression of ubiquitin carboxy-terminal hydrolase-L1 and -L3 mRNA predicts early recurrence in patients with invasive breast cancer. Miyoshi Y, Nakayama S, Torikoshi Y, Tanaka S, Ishihara H, Taguchi T, Tamaki Y, Noguchi S, Cancer Sci 2006 97 523 529 10.1111/j.1349-7006.2006.00202.x 16734731 (Pubitemid 43811594)
31. Over-expression of ubiquitin carboxy terminal hydrolase-L1 induces apoptosis in breast cancer cells. Wang WJ, Li QQ, Xu JD, Cao XX, Li HX, Tang F, Chen Q, Yang JM, Xu ZD, Liu XP, Int J Oncol 2008 33 1037 1045 18949367
32. Ubiquitin C-terminal hydrolase-L1 is a key regulator of tumor cell invasion and metastasis. Kim HJ, Kim YM, Lim S, Nam YK, Jeong J, Kim HJ, Lee KJ, Oncogene 2009 28 117 127 10.1038/onc.2008.364 18820707
33. Effect of liposomal transfection of UCH-L1 siRNA on proliferation and apoptosis of lung cancer cell line H157. Qu X, Wang Y, Zhongguo Fei Ai Za Zhi 2010 13 292 296 20677552
34. Expression of the protein gene product 9.5, PGP9.5, is correlated with T-status in non-small cell lung cancer. Sasaki H, Yukiue H, Moriyama S, Kobayashi Y, Nakashima Y, Kaji M, Fukai I, Kiriyama M, Yamakawa Y, Fujii Y, Jpn J Clin Oncol 2001 31 532 535 10.1093/jjco/hye113 11773260 (Pubitemid 33138237)
35. Subtyping of undifferentiated non-small cell carcinomas in bronchial biopsy specimens. Loo PS, Thomas SC, Nicolson MC, Fyfe MN, Kerr KM, J Thorac Oncol 2010 5 442 447 10.1097/JTO.0b013e3181d40fac 20195168
36. Global down-regulation of HOX gene expression in PML-RARalpha + acute promyelocytic leukemia identified by small-array real-time PCR. Thompson A, Quinn MF, Grimwade D, O'Neill CM, Ahmed MR, Grimes S, McMullin MF, Cotter F, Lappin TR, Blood 2003 101 1558 1565 10.1182/blood.V101.4.1558 12560242 (Pubitemid 36182534)
37. Erythropoietin receptor expression in non-small cell lung carcinoma: a question of antibody specificity. Brown WM, Maxwell P, Graham AN, Yakkundi A, Dunlop EA, Shi Z, Johnston PG, Lappin TR, Stem Cells 2007 25 718 722 17110616 (Pubitemid 46354231)
38. Endoplasmic reticulum stress contributes to the cell death induced by UCH-L1 inhibitor. Tan YY, Zhou HY, Wang ZQ, Chen SD, Mol Cell Biochem 2008 318 109 115 10.1007/s11010-008-9862-x 18622688
39. Identifying apoptosis-evasion proteins/pathways in human hepatoma cells via induction of cellular hormesis by UV irradiation. Hsieh SY, Hsu CY, He JR, Liu CL, Lo SJ, Chen YC, Huang HY, J Proteome Res 2009 8 3977 3986 10.1021/pr900289g 19545154
40. Pak1 and Pak2 mediate tumor cell invasion through distinct signaling mechanisms. Coniglio SJ, Zavarella S, Symons MH, Mol Cell Biol 2008 28 4162 4172 10.1128/MCB.01532-07 18411304 (Pubitemid 351812999)
41. Discovery of inhibitors that elucidate the role of UCH-L1 activity in the H1299 lung cancer cell line. Liu Y, Lashuel HA, Choi S, Xing X, Case A, Ni J, Yeh LA, Cuny GD, Stein RL, Lansbury PT Jr, Chem Biol 2003 10 837 846 10.1016/j.chembiol.2003.08.010 14522054 (Pubitemid 37171901)